Weekly News Amount
Financing ${lastRankDetail.financing_pages.length}
Product ${lastRankDetail.product_pages.length}
Negative ${lastRankDetail.sentiment_pages.length}
StoneWise is a technology company dedicated to using artificial intelligence to drive the research and development of new drugs. The purpose is to bring a new perspective to the pharmaceutical industry with technology and innovation, update the previous single-engine innovative drug research and development model with experts as the core, and build a machine+expert dual-engine research and development model driven by science and technology. Integrate cutting-edge artificial intelligence, big data and pharmaceutical chemistry, computational chemistry, computational biology, organic chemistry, pharmacology, toxicology, molecular medicine, clinical medicine and other disciplines to create a world-leading service platform for research and development of small molecule innovative drugs. To provide innovative drug R&D enterprises and institutions with integrated small molecule innovative drug design schemes, such as medical knowledge map, molecular generation and design, activity prediction, ADMET prediction, synthetic accessibility prediction and customized model training, so as to improve the efficiency and success rate of key links in new drug R&D, such as the discovery of emerging compounds, emerging to leading, leading optimization and clinical candidate drug discovery


Events ${currentEventsPage.count} Events
Events (${currentEventsPage.count}) Date
Nothing Happens :-(
${e.desp} ${e.date}
News ${ rankDetail.pages.length } News Articles ${currentTimeRange.start} ~ ${currentTimeRange.end}
Article (${rankDetail.pages.length}) Tag
${article.en_title} ${article.tag}
Industry Financing Info


Intelligence 0 Research Briefs


Competitors 0 Competitors